Ultralife (ULBI) Competitors $4.78 -0.10 (-2.05%) As of 11:44 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ULBI vs. RONI, AMPX, EAF, SES, FREY, SLDP, NVX, GAUZ, NRGV, and SKYXShould you be buying Ultralife stock or one of its competitors? The main competitors of Ultralife include Rice Acquisition Corp. II (RONI), Amprius Technologies (AMPX), GrafTech International (EAF), SES AI (SES), FREYR Battery (FREY), Solid Power (SLDP), NOVONIX (NVX), Gauzy (GAUZ), Energy Vault (NRGV), and SKYX Platforms (SKYX). These companies are all part of the "electrical equipment" industry. Ultralife vs. Rice Acquisition Corp. II Amprius Technologies GrafTech International SES AI FREYR Battery Solid Power NOVONIX Gauzy Energy Vault SKYX Platforms Rice Acquisition Corp. II (NYSE:RONI) and Ultralife (NASDAQ:ULBI) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk. Do analysts rate RONI or ULBI? Ultralife has a consensus target price of $14.00, suggesting a potential upside of 186.89%. Given Ultralife's stronger consensus rating and higher possible upside, analysts plainly believe Ultralife is more favorable than Rice Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rice Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ultralife 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, RONI or ULBI? Rice Acquisition Corp. II has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500. Comparatively, Ultralife has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Which has stronger valuation and earnings, RONI or ULBI? Ultralife has higher revenue and earnings than Rice Acquisition Corp. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRice Acquisition Corp. IIN/AN/A$4.07MN/AN/AUltralife$165.15M0.49$7.20M$0.558.87 Is RONI or ULBI more profitable? Ultralife has a net margin of 5.44% compared to Rice Acquisition Corp. II's net margin of 0.00%. Ultralife's return on equity of 7.92% beat Rice Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Rice Acquisition Corp. IIN/A -17.93% -4.49% Ultralife 5.44%7.92%5.90% Does the MarketBeat Community favor RONI or ULBI? Ultralife received 267 more outperform votes than Rice Acquisition Corp. II when rated by MarketBeat users. CompanyUnderperformOutperformRice Acquisition Corp. IIN/AN/AUltralifeOutperform Votes26771.77% Underperform Votes10528.23% Does the media prefer RONI or ULBI? In the previous week, Ultralife had 13 more articles in the media than Rice Acquisition Corp. II. MarketBeat recorded 13 mentions for Ultralife and 0 mentions for Rice Acquisition Corp. II. Ultralife's average media sentiment score of 0.04 beat Rice Acquisition Corp. II's score of 0.00 indicating that Ultralife is being referred to more favorably in the news media. Company Overall Sentiment Rice Acquisition Corp. II Neutral Ultralife Neutral Do insiders and institutionals have more ownership in RONI or ULBI? 22.5% of Rice Acquisition Corp. II shares are owned by institutional investors. Comparatively, 30.7% of Ultralife shares are owned by institutional investors. 20.0% of Rice Acquisition Corp. II shares are owned by company insiders. Comparatively, 39.9% of Ultralife shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryUltralife beats Rice Acquisition Corp. II on 14 of the 14 factors compared between the two stocks. Remove Ads Get Ultralife News Delivered to You Automatically Sign up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ULBI vs. The Competition Export to ExcelMetricUltralifeelectrical machinery, equipment, & supplies IndustryComputer SectorNASDAQ ExchangeMarket Cap$81.14M$770.79M$23.09B$7.92BDividend YieldN/A2.45%2.83%4.04%P/E Ratio8.878.7142.1018.81Price / Sales0.499.661,974.5188.91Price / Cash8.9715.9534.6334.64Price / Book0.647.736.034.18Net Income$7.20M-$70.66M$735.26M$247.10M7 Day Performance-10.79%-4.28%-1.39%-2.72%1 Month Performance-17.29%-6.51%49,733.46%-3.90%1 Year Performance-49.33%-16.32%52,623.42%-0.11% Ultralife Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ULBIUltralife2.9635 of 5 stars$4.74-2.9%$14.00+195.4%-48.9%$78.81M$165.15M8.62560Earnings ReportNews CoverageGap DownRONIRice Acquisition Corp. IIN/A$2.94-3.0%N/A-77.1%$355.01MN/A0.0024High Trading VolumeAMPXAmprius Technologies4.1376 of 5 stars$3.30+5.9%$9.43+186.1%+15.5%$348.74M$17.22M-7.3250Gap UpHigh Trading VolumeEAFGrafTech International2.031 of 5 stars$1.01+1.5%$1.90+89.1%-36.0%$258.55M$538.78M-1.971,350News CoveragePositive NewsSESSES AI1.7334 of 5 stars$0.59+12.2%$1.25+111.5%-64.6%$215.51M$2.04M-2.57130Short Interest ↑Gap DownHigh Trading VolumeFREYFREYR Battery2.1774 of 5 stars$1.49-5.1%$4.00+168.5%-30.7%$209.33MN/A-1.96210SLDPSolid Power1.0283 of 5 stars$1.15+3.6%$2.67+131.9%-45.0%$209.29M$20.14M-2.35240Gap DownNVXNOVONIX2.0901 of 5 stars$1.30+6.6%$4.00+207.7%-54.7%$206.71M$5.85M0.00N/AGAUZGauzy2.079 of 5 stars$9.60+1.9%$14.25+48.4%N/A$182.92M$103.53M0.00N/ANRGVEnergy Vault2.0228 of 5 stars$0.94-1.6%$1.60+70.6%-53.9%$142.69M$46.20M-1.4470News CoverageGap DownSKYXSKYX Platforms2.3062 of 5 stars$1.35+4.7%$4.00+196.3%-0.8%$138.38M$84.77M-3.3830Upcoming EarningsAnalyst RevisionGap Down Remove Ads Related Companies and Tools Related Companies Rice Acquisition Corp. II Competitors Amprius Technologies Competitors GrafTech International Competitors SES AI Competitors FREYR Battery Competitors Solid Power Competitors NOVONIX Competitors Gauzy Competitors Energy Vault Competitors SKYX Platforms Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ULBI) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ultralife Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ultralife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ULBI Stock Free ULBI Stock Alerts